Hypoxia regulates macrophage functions in inflammation

Journal of Immunology

Volumn 175, Issue 10, 2005, Pages 6257-6263

  Murdoch, Craig ^a   Muthana, Munitta ^a   Lewis, Claire E ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ARGINASE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLOOXYGENASE 2; FIBRONECTIN; GAMMA INTERFERON; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LEPTIN; MATRILYSIN; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B; PROSTAGLANDIN E2; PROSTAGLANDIN F2; ROUNDABOUT RECEPTOR; SCATTER FACTOR; THROMBOPLASTIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ATHEROSCLEROSIS; BACTERIAL INFECTION; GENE EXPRESSION REGULATION; HEART INFARCTION; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY;

EID: 27744603002     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.10.6257     Document Type: Short Survey

References (87)

1. Burke, B., A. Giannoudis, K. P. Corke, D. Gill, M. Wells, L. Ziegter-Heitbrock, and C. E. Lewis. 2003. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am. J. Pathol. 163: 1233-1243.
2. Talks, K. L., H. Turley, K. C. Gatter, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, and A. L. Harris. 2000. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157: 411-421.
3. Semenza, G. L. 2002. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64: 993-998.
4. Lewis, C. E., and C. Murdoch. 2005. Macrophage responses to hypoxia: implications for tumor progression. Am. J. Pathol. 167: 627-635.
5. Coussens, L. M., and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860-867.
6. Bingle, L., N. J. Brown, and C. E. Lewis. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 196; 254-265.
7. Murdoch, C., A. Giannoudis, and C. E. Lewis. 2004. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104; 2224-2234.
8. Lin, E. Y., A. V. Nguyen, R. G. Russell, and J. W. Pollard. 2001. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193: 727-740.
9. Vaupel, P., D. K. Kelleher, and M. Hockel. 2001. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin. Oncol. 28: 29-35.
10. Kennedy, A. S., J. A. Raleigh, G. M. Perez, D. P. Calkins, D. E. Thrall, D. B. Novotny, and M. A. Varia. 1997. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunofustochemical assays. Int. J. Radiat. Oncol. Biol. Phys. 37: 897-905.
11. Grimshaw, M. J., and F. R. Balkwill. 2001. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation: a potential mechanism. Eur. J. Immunol. 31: 480-489.
12. Lewis, J. S., R. J. Landers, J. C. Underwood, A. L. Harris, and C. E. Lewis. 2000. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularjzed areas of breast carcinomas. J. Pathol. 192: 150-158.
13. Wang, F. Q., J. So, S. Reierstad, and D. A. Fishman. 2005. Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int. J. Cancer 114: 19-31.
14. Griffiths, L., K. Binley, S. Iqball, O. Kan, P. Maxwell, P. Ratcliffe, C. Lewis, A. Harris, S. Kingsman, and S. Naylor. 2000. The macrophage: a novel system to deliver gene therapy to pathological hypoxia. Gene Ther, 7: 255-262.
15. Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340: 115-126.
16. de Villiers, W. J., and E. J. Smart. 1999. Macrophage scavenger receptors and foam cell formation. J. Leukocyte Biol. 66: 740-746.
17. Zemplenyi, T., D. W. Crawford, and M. A. Cole. 1989. Adaptation to arterial wail hypoxia demonstrated in vivo with oxygen microcathodes. Atherosclerosis 76; 173-179.
18. Bjornheden, T., M. Levin, M. Evaldsson, and O. Wiklund. 1999. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler. Thromb. Vasc. Biol. 19: 870-876.
19. Rydberg, E. K., A. Krettek, C. Ullstrom, K. Ekstrom, P. A. Svensson, L. M. S. Carlsson, A. C. Jonsson-Rylander, G. I. Hansson, W. McPheat, O. Wiklund, et al. 2004. Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler. Thromb. Vasc. Biol. 24: 2040-2045.
20. Nakazato, K., T. Ishibashi, J. Shindo, M. Shiomi, and Y. Maruyama, 1996. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am. J. Pathol. 149: 1831-1838.
21. Nakazato, K., T. Ishibashi, K. Nagata, Y. Seino, Y. Wada, T. Sakamoto, R. Matsuoka, T. Teramoto, M. Sekimata, Y. Homma, and Y. Maruyama, 2001. Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia. Atherosclerosis 155: 439-444.
22. Niemeier, A., M. Gafvels, J. Heeren, N. Meyer, B. Angelin, and U. Beisiegel. 1996. VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J. Lipid Res. 37: 1733-1742.
23. Argraves, K. M., K. F. Kozarsky, J. T. Fallon, P. C. Harpel, and D. K. Strickland. 1997. The atherogenic lipoprotein Lp(α) is internalized and degraded in a process mediated by the VLDL receptor. J. Clin. Invest. 100: 2170-2181.
24. Rollins, B. J. 1997. Chemokines. Blood 90: 909-928.
25. Liu, Y., L. M. Hulten, and O. Wiklund. 1997. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler. Thromb. Vasc. Biol. 17: 317-323.
26. Boisvert, W. A., L. K. Curtiss, and R. A. Terkeltaub. 2000. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol. Res. 21: 129-137.
27. Rydberg, E. K., L. Salomonsson, L. M. Hulten, K. Noren, G. Bondjers, O. Wiklund, T. Bjornheden, and B. G. Ohlsson. 2003. Hypoxia increases 25-hydroxychoIesterol-induced interleukin-8 protein secretion in human macrophages. Atherosclerosis 170: 245-252.
28. Tsukamoto, Y., K. Kuwabara, S. Hirota, J. Ikeda, D. Stern, H. Yanagi, M. Matsumoto, S. Ogawa, and Y. Kitamura. 1996. 150-kD oxygen-regulated protein is expressed in human atherosclerotic plaques and allows mononuclear phagocytes to withstand cellular stress on exposure to hypoxia and modified low density lipoprotein. J. Clin. Invest. 98: 1930-1941.
29. Ozawa, K., K. Kuwabara, M. Tamatani, K. Takatsuji, Y. Tsukamoto, S. Kaneda, H. Yanagi, D. M. Stern, Y. Eguchi, Y. Tsujimoto, et al. 1999. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J. Biol. Cbem. 274: 6397-6404.
30. Schmeisser, A., R. Marquetant, T. Illmer, C. Graffy, C. D. Garlichs, D. Bockler, D. Menschikowski, R. Braun-Dullaeus, W. G. Daniel, and R. H. Strasser. 2005. The expression of macrophage migration inhibitory factor 1α (MIF 1α) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis 178: 83-94.
31. Yang, Y., P. Degranpre, A. Kharfi, and A. Akoum. 2000. Identification of macrophage migration inhibitory factor as a potent endothelial cell growth-promoting agent released by ectopic human endometrial cells. J. Clin. Endocrinol Metab. 85: 4721-4727.
32. Burger-Kentischer, A., H. Gobel, R. Kleemann, A. Zernecke, R. Bucala, L. Leng, D. Finkelmeier, G. Geiger, H. E. Schaefer, A. Schober, et al. 2005. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis. In press.
33. Chen, Y. X., Y. Nakashima, K. Tanaka, S. Shiraishi, K. Nakagawa, and K. Sueishi. 1999. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler. Thromb. Vasc. Biol. 19: 131-139.
34. Ross, R., J. Masuda, E. W. Raines, A. M. Gown, S. Katsuda, M. Sasahara, L. T. Malden, H. Masuko, and H. Sato. 1990. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248: 1009-1012.
35. Tipping, P. G., and W. W. Hancock. 1993. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am. J. Pathol. 142: 1721-1728.
36. Yla-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, T. Sarkioja, T. Yoshimura, E. J. Leonard, J. L. Wirztum, and D. Steinberg. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88: 5252-5256.
37. Galis, Z. S., G. K. Sukhova, M. W. Lark, and P. Libby. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in, vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503.
38. Halpert, I., U. I. Sires, J. D. Roby, S. Potter-Perigo, T. N. Wight, S. D. Shapiro, H. G. Welgus, S. A. Wickline, and W. C. Parks. 1996. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. USA 93: 9748-9753.
39. van der Wal, A. C., A. E. Becker, C. M. van der Loos, A. J. Tigges, and P. K. Das. 1994. Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept. Coron. Artery Dis. 5: 463-469.
40. Lewis, J. S., P. Herrero, T. L. Sharp, J. A. Engelbach, Y. Fujibayashi, R. Laforest, A. Kovacs, R. J. Gropler, and M. J. Welch. 2002. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)- methylthiosemicarbazone). J. Nucl. Med. 43: 1557-1569.
41. Azzawi, M., S. W. Kan, V. Hillier, N. Yonan, I. V. Hutchinson, and P. S. Hasleton. 2005. The distribution of cardiac macrophages in myocardial ischaemia and cardiomyopathy. Histopathology 46: 314-319.
42. Jurgensen, J. S., C. Rosenberger, M. S. Wiesener, C. Warnecke, J. H. Horstrup, M. Grafe, S. Philipp, W. Griethe, P. H. Maxwell, U. Frei, et al. 2004. Persistent induction of HIF-1α and -2α in cardiomyocytes and stromal cells of ischemic myocardium. FASEB J. 18: 1415-1417.
43. Li, J., L. F. Brown, R. J. Laham, R. Volk, and M. Simons. 1997. Macrophage-dependent regulation of syndecan gene expression. Circ. Res. 81: 785-796.
44. Li, J., M. Post, R. Volk, Y. Gao, M. Li, C. Metais, K. Sato, J. Tsai, W. Aird, R. D, Rosenberg, et al. 2000. PR39, a peptide regulator of angiogenesis. Nat. Med. 6: 49-55.
45. Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
46. Taylor, P. C., and B. Sivakumar. 2005. Hypoxia and angiogenesis in rheumatoid arthritis. Curr. Opin. Rheumatol. 17: 293-298.
47. Lund-Olesen, K. 1970. Oxygen tension in synovial fluids. Arthritis Rheum. 13: 769-776.
48. Peters, C. L., C. J. Morris, P. I. Mapp, D. R. Blake, C. E. Lewis, and V. R. Winrow. 2004. The transcription factors hypoxia-inducible factor 1α and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum. 50: 291-296.
49. Hollander, A. P., K. P. Corke, A. J. Freemont, and C. E. Lewis. 2001. Expression of hypoxia-inducible factor 1α by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44: 1540-1544.
50. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
51. Hitchon, C., K. Wong, G. Ma, J. Reed, D. Lyttle, and G. El. 2002. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum. 46: 2587-2597.
52. Rodenburg, R. J., F. H. van Den Hoogen, P. Barrera, W. J. van Venrooij, and L. B. van De Putte. 1999. Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients. Ann. Rheum. Dis. 58: 648-652.
53. Ikeda, M., Y. Hosoda, S. Hirose, Y. Okada, and E. Ikeda. 2000. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. J. Pathol. 191: 426-433.
54. MacNaul, K. L., N. I. Hutchinson, J. N. Parsons, E. K. Bayne, and M. J. Tocci. 1990. Analysis of IL-1 and TNF-α gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. J. Immunol 145: 4154-4166.
55. Stewart, R. J., J. A. Duley, I. Rosman, R. Fraser, and R. A. Allardyce. 1981. The wound fibroblast and macrophage. I. Wound cell population changes observed in tissue culture. Br. J. Surg. 68: 125-128.
56. Allen, D. B., J. J. Maguire, M. Mahdavian, C. Wicke, L. Marcocci, H. Scheuenstuhl, M. Chang, A. X. Le, H. W. Hopf, and T. K. Hunt. 1997. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch. Surg. 132: 991-996
57. Niinikoski, J., C. Heughan, and T. K. Hunt. 1971. Oxygen and carbon dioxide tensions in experimental wounds. Surg. Gynecol. Obstet. 133: 1003-1007.
58. Crowther, M., N. J. Brown, E. T. Bishop, and C. E. Lewis. 2001. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukocyte Biol. 70: 478-490.
59. Haroon, Z. A., J. A. Raleigh, C. S. Greenberg, and M. W. Dewhirst. 2000. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann. Surg. 231: 137-147.
60. Albina, J. E., W. L. Henry, B. MastroFrancesco, B. A. Martin, and J. S. Reichner. 1995. Macrophage activation by culture in an anoxic environment. J. Immunol. 155: 4391-4396.
61. Albina, J. E., C. D. Mills, W. L. Henry, Jr., and M. D. Caldwell. 1990. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol. 144: 3877-3880.
62. Swift, M. E., H. K. Kleinman, and L. A. Di Pietro. 1999. Impaired wound repair and delayed angiogenesis in aged mice. Lab. Invest. 79: 1479-1487.
63. Rappolee, D. A., D. Mark, M. J. Banda, and Z. Werb. 1988. Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science 241: 708-712.
64. Kibe, Y., H. Takenaka, and S. Kishimoto. 2000. Spatial and temporal expression of basic fibroblast growth factor protein during wound healing of rat skin. Br. J. Dermatol. 143: 720-727.
65. Fahey, T. J., B. Sherry, K. J. Tracey, S. van Deventer, W. G. Jones, J. P. Minei, S. Morgello, G. T. Shires, and A. Cerami. 1990. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine 2: 92-99.
66. Kelly, C. J., H. Gallagher, B. A. Wolf, and J. M. Daly. 1994. Alterations in macrophage signal transduction pathways mediate post-traumatic changes in macrophage function. J. Surg. Res. 57: 221-226.
67. Ozawa, K., T. Kondo, O. Hori, Y. Kitao, D. M. Stern, W. Eisenmenger, S. Ogawa, and T. Ohshima, 2001. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J. Clin. Invest. 108: 41-50.
68. Gu, Q., D. Wang, Y. Gao, J. Zhou, R. Peng, Y. Cui, G. Xia, Q. Qing, H. Yang, J. Liu, and M. Zhao. 2002. Expression of MMP1 in surgical and radiation-impaired wound healing and its effects on the healing process. J. Environ. Pathol. Toxicol. Oncol. 21: 71-78.
69. 2 and pH. Ann. Surg. 213: 253-260.
70. Blouin, C. C., E. L. Page, G. M. Soucy, and D. E. Richard. 2004. Hypoxie gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1α. Blood 103: 1124-1130.
71. Peyssonnaux, C., V. Datta, T. Cramer, A. Doedens, E. A. Theodorakis, R. L. Gallo, N. Hurtado-Ziola, V. Nizet, and R. S. Johnson. 2005. HIF-1α expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115: 1806-1815.
72. Shatrov, V. A., V. V. Sumbayev, J. Zhou, and B. Brune. 2003. Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1α (HIF-1α) accumulation via redox-dependent mechanisms. Blood 101: 4847-4849.
73. Haddad, J. J., and H. L. Harb. 2005. Cytokines and the regulation of hypoxia-inducible factor (HIF)-1α. Int. Immunopharmacol. 5: 461-483.
74. Hirani, N., F. Antonicelli, R. M. Strieter, M. S. Wiesener, C. Haslett, and S. C. Donnelly. 2001. The regulation of interleukin-8 by hypoxia in human macrophages: a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol. Med. 7: 685-697.
75. Albina, J. E., E. J. Mahoney, J. M. Daley, D. E. Wesche, S. M. Morris, Jr., and J. S. Reichner. 2005. Macrophage arginase regulation by CCAAT/enhancer-binding protein β. Shock 23: 168-172.
76. Chandel, N. S., W. C. Trzyna, D. S. McClintock, and P. T. Schumacker. 2000. Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia andendotoxin. J. Immunol. 165: 1013-1021.
77. Zampetaki, A., S. A. Mitsialis, J. Pfeilschifter, and S. Koutembanas. 2004. Hypoxia induces macrophage inflammatory ptotein-2 (MIP-2) gene expression in murine macrophages via NF-κB: the prominent role of p42/p44 and PI3 kinase pathways. FASEB J. 18:U808-U827.
78. White, J. R., R. A. Harris, S. R. Lee, M. H. Craigon, K. Binley, T. Price, G. L. Beard, C. R. Mundy, and S. Naylor. 2004. Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 83: 1-8.
79. Compeau, C. G., J. Ma, K. N. DeCampos, T. K. Waddell, G. F. Brisseau, A. S. Slutsky, and O. D. Rotstein. 1994. In situ ischemia and hypoxia enhance alveolar macrophage tissue factor expression. Am. J. Respir. Cell Mol. Biol. 11: 446-455.
80. Angele, M. K., M. G. Schwacha, N. Smail, R. A. Catania, A. Ayala, W. G. Cioffi, and I. H. Chaudry. 1999. Hypoxemia in the absence of blood loss upregulates iNOS expression and activity in macrophages. Am. J. Physiol. 276: C285-C290.
81. Scannell, G. 1996. Leukocyte responses to hypoxic/ischemic conditions. New Horiz. 4: 179-183.
82. 2 release and depresses macrophage antigen presentation. Am. J. Physiol. 264: R655-R660.
83. Murata, Y., T. Ohteki, S. Koyasu, and J. Hamuro. 2002. IFN-γ and pro-inflammatory cytokine production by anrigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur. J. Immunol 32: 2866-2873.
84. Bosco, M. C., M. Puppo, S. Pastorino, Z. Mi, G. Melillo, S. Massazza, A. Rapisarda, and L. Varesio. 2004. Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J. Immunol. 172: 1681-1690.
85. Schioppa, T., B. Uranchimeg, A. Saccani, S. K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, et al. 2003. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198: 1391-1402.
86. Bosco, M. C., G. Reffo, M. Puppo, and L. Varesio. 2004. Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages. Cell. Immunol. 228: 1-7.
87. Lahat, N., M. A. Rahat, M. Ballan, C. Weiss, M. Ehgelmayer, and H. Bittetman. 2003. Hypoxia reduces CD80 expression on monocytes but enhances their LPS-stimulated TNF-α secretion. J. Leukocyte Biol. 74: 197-205.